Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. - sprookjes - yvandenbroek - TriplyDB

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

http://www.wikidata.org/entity/Q34344151

about

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care Molecular biology of cantharidin in cancer cells Artemisinins: their growing importance in medicine Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target Anticancer properties of distinct antimalarial drug classes Ameliorative Effects of Curcumin on Artesunate-Induced Subchronic Toxicity in Testis of Swiss Albino Male Mice Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate.Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells.The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells.Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin.Amplification activation loop between caspase-8 and -9 dominates artemisinin-induced apoptosis of ASTC-a-1 cells.Development of artemisinin compounds for cancer treatment.Effects of different concentrations of artemisinin and artemisinin-iron combination treatment on Madin Darby Canine Kidney (MDCK) cells.NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death Nox4-dependent ROS modulation by amino endoperoxides to induce apoptosis in cancer cells Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production Anti-cancer natural products isolated from chinese medicinal herbs Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomes Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma.Comparative cytotoxicity of artemisinin and cisplatin and their interactions with chlorogenic acids in MCF7 breast cancer cells.Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds.Therapeutic potential of iron chelators in diseases associated with iron mismanagement.Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity.Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs.Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.Anticancer activities of artemisinin and its bioactive derivatives.Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2 Toxicity of the antimalarial artemisinin and its dervatives.Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.Antitumor effects of artesunate on human breast carcinoma MCF-7 cells and IGF-IR expression in nude mice xenografts.Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua.Transport processes of radiopharmaceuticals and -modulators.Artemisinin derivatives: a patent review (2006 - present).Terpenoids: natural products for cancer therapy.

P2860

Q26851160-AFE0E0F0-7AEC-44DB-AC2A-1E48622BA0B9 Q27480937-9F698468-7CCA-4F00-918D-E0BCB0687CBB Q27489880-396B6A41-4E6E-44FC-B8F9-786D3F547B80 Q28388335-BED4FC76-DF19-4064-B923-0194E439EA02 Q28471656-11932A7F-7818-4ABB-9333-6E7E1AAA3055 Q28538116-7205BA62-826B-4516-B5CD-B4CF43BCE56D Q28551461-273FBB7F-EECC-4940-AAF4-BE43134444C5 Q33295383-92703306-C2EB-4098-BFA5-30DB7F28411B Q33297414-A1B1F59E-359D-4726-B642-E3DA467C0E98 Q33626573-B82EDAF2-C5F0-4FD2-A8DD-431D7878C46D Q33739996-EE949DF2-136D-4B0A-80EF-1A1776C86C17 Q34204208-884193C1-4BB2-4955-81F5-C05BA78298CD Q34296810-55F1167D-4F59-4B03-BFD5-38890E82A028 Q34333019-9A175B10-975D-4E9A-9684-1583986C340B Q34333336-9F325D90-5589-46E2-A85C-CE08C4A2D458 Q34334633-CD1D1572-9527-4FF6-81FA-CFF0A6652B25 Q34675798-72B83B57-6579-43DB-A6B0-CBA9B0BD2C07 Q35143916-41087C5D-8EBE-429F-9E22-263D90DD7138 Q35585226-133A1636-60F0-4F72-A8D1-4CC01D35A80F Q35709845-F7D8971F-1319-4EA1-B820-8C0BF4652375 Q35742191-756B6C3A-C8C3-45A3-AF1D-A4A3FAD4035D Q35863615-6044FCDB-199C-4373-977A-6EFDF224F79E Q36268319-6E60B211-EDAD-49D1-99DE-35C1AAC482A2 Q36461028-53B25D58-A155-445D-B5F8-1C19FA00CBBF Q36545062-FE2D6366-4A9E-49D5-84F8-9EF6672259A6 Q36775054-50BB9D2D-DAFF-4B95-8999-D46D50F15CA2 Q36811863-29D5DDEE-4278-49E1-BF10-1FD1043CE41F Q36916456-8C823F16-A80E-4BCE-9970-CB8985A190D7 Q37090690-B49E5805-53D1-4AF2-A834-C44FC5E5B844 Q37318264-8C4F40FA-602C-4D60-A34B-F27DC5A908E4 Q37543809-2CEEAD8F-EE46-4E72-892B-F8C143800B4D Q37626137-A3410816-61DA-46F2-8404-C9A3A9CC259A Q37683039-54CEE2B4-F139-4401-93BC-80FC4AF1D940 Q37693152-1B495319-D459-498D-8E41-644CC57E90AB Q37699414-424C2968-18AE-49E1-92AE-2AC8787C790B Q37725400-C53EDF89-B873-4303-B0CF-647B4ABCAF97 Q37732720-CC000AC6-5AF2-427C-81EE-0777EF5A3E51 Q37885468-50C0C150-3709-4A4E-AC5B-4DF5B8263EAF Q38042732-409BA53C-17E6-4C24-A8DD-E2E8B10174F9 Q38054798-D90361E4-CEC1-49BB-B913-F2A417FA3F94

P2860

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

http://www.wikidata.org/entity/Q34344151

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@ast

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@en

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@nl

type

label

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@ast

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@en

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@nl

prefLabel

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@ast

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@en

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@nl

P1433

Q34344151-374762BD-7EFF-4218-9C37-B5AB82BE614D

P1476

Q34344151-01178947-8E22-4979-ADC3-84018E370170

P2093

Q34344151-660521A4-5AE9-47E0-9D8D-C7479C343945

Q34344151-72299AFE-1F5C-43A8-9EEB-EA46FACEE029

Q34344151-740D7899-1805-41DF-AA3E-12D8103231F6

Q34344151-8F3E30D5-4304-4AD5-877A-D9292AC85A22

Q34344151-C44A8806-F627-4770-AA61-BAC03A195E01

Q34344151-D08E93F6-1FC3-4135-B395-019F73F04A9F

Q34344151-DDE06152-F9E6-453A-BBF0-527639669808

Q34344151-F1473A42-9BDB-40E1-977D-39523C1A1BDA

Q34344151-F3AED18A-1560-4480-9D60-2E5FB3108010

Q34344151-FC3A5F8A-280C-4104-A706-9477CC650B7A

P304

Q34344151-098AEF4B-9D84-41DB-A3AF-0FF2B60A3DB3

P31

Q34344151-DCF9F8DF-6C5C-4BE0-BD8C-04C42099E662

P356

Q34344151-8C1CA231-0EBC-4B7C-B0BF-0E62B264EDE9

P433

Q34344151-7DF4E7B0-3DE5-4FBE-8512-586AFBD0CF85

P478

Q34344151-2B5A9638-3CD8-4A4F-B45C-0F272647BE48

P50

Q34344151-F5C5BDC7-B8C3-4BF0-A065-C60F4D0E6B41

P577

Q34344151-CC4CA376-99AF-4585-B137-5C1A236FEE8C

P5875

Q34344151-E6E26744-9391-4029-9461-C1E846564CA7

P698

Q34344151-B973A856-4F47-4C43-905D-9A5190111012

P921

Q34344151-0F34F5FD-144F-4343-904C-9985F4BC08B2

Q34344151-CA21D2AA-2D3F-4DE9-A4CE-444FD7EB78F6

P356

J.FREERADBIOMED.2004.06.023

P1433

Free Radical Biology and Medicine

P1476

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron.

@en

P2093

Achille Benakis

http://www.w3.org/2001/XMLSchema#string

Bernd Kaina

http://www.w3.org/2001/XMLSchema#string

Daniel Steinbach

http://www.w3.org/2001/XMLSchema#string

Franz Oesch

http://www.w3.org/2001/XMLSchema#string

Maja Tomicic

http://www.w3.org/2001/XMLSchema#string

Manfred Marschall

http://www.w3.org/2001/XMLSchema#string

Marta R Romero

http://www.w3.org/2001/XMLSchema#string

Ralf Häfer

http://www.w3.org/2001/XMLSchema#string

Rolf Rauh

http://www.w3.org/2001/XMLSchema#string

Thomas Efferth

http://www.w3.org/2001/XMLSchema#string

P304

998-1009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FREERADBIOMED.2004.06.023

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Stamminger

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8376730

http://www.w3.org/2001/XMLSchema#string

P698

15336316

http://www.w3.org/2001/XMLSchema#string

P921